BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23265708)

  • 1. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
    Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
    Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.
    Osako T; Iwase T; Kimura K; Yamashita K; Horii R; Yanagisawa A; Akiyama F
    Cancer; 2011 Oct; 117(19):4365-74. PubMed ID: 21437889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
    Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
    Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.
    Piñero-Madrona A; Ruiz-Merino G; Bernet L; Miguel-Martínez B; Vicente-García F; Viguri-Díaz MA; Giménez-Climent J
    Breast; 2014 Dec; 23(6):859-64. PubMed ID: 25283682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
    Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
    Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status.
    Milner TD; de Lusignan S; Jones S; Jackson PA; Layer GT; Kissin MW; Irvine TE
    Breast; 2015 Oct; 24(5):568-75. PubMed ID: 26032111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer.
    Yaguchi Y; Sugasawa H; Tsujimoto H; Takata H; Nakabayashi K; Ichikura T; Ono S; Hiraki S; Sakamoto N; Horio T; Kumano I; Otomo Y; Mochizuki H; Yamamoto J; Hase K
    Ann Surg Oncol; 2011 Aug; 18(8):2289-96. PubMed ID: 21301968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).
    Godey F; Leveque J; Tas P; Gandon G; Poree P; Mesbah H; Lavoue V; Quillien V; Athias CB
    Breast Cancer Res Treat; 2012 Jan; 131(2):509-16. PubMed ID: 21993859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method.
    Okamoto S; Niikura H; Nakabayashi K; Hiyama K; Matoda M; Takeshima N; Watanabe M; Nagase S; Otsuki T; Yaegashi N
    Gynecol Oncol; 2013 Sep; 130(3):530-6. PubMed ID: 23811115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
    Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
    J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-sentinel lymph node analysis with one-step nucleic acid amplification in breast cancer patients.
    Ogiya A; Iwase T; Kitagawa D; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F
    Breast; 2015 Aug; 24(4):476-80. PubMed ID: 25963136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
    Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
    Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.